Literature DB >> 113377

The in vitro activity of mezlocillin when combined with cefoxitin or clavulanic acid.

R Wise, A P Gillett, J M Andrews.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 113377     DOI： 10.1093/jac/5.3.301

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  6 in total

Review 1.  Beta-lactamase inhibitors from laboratory to clinic.

Authors:  K Bush
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

2.  Twenty-one years of beating beta-lactamases.

Authors:  F W O'Grady
Journal:  Br Med J (Clin Res Ed)       Date:  1982-02-06

3.  In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates.

Authors:  P C Fuchs; A L Barry; C Thornsberry; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

4.  Augmentation of the in vitro activity of azlocillin against Bacteroides fragilis by clavulanic acid.

Authors:  M B Bansal; S K Chuah; H Thadepalli
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

5.  A combination of amoxicillin and clavulanic acid in the treatment of respiratory tract infections caused by amoxicillin-resistant haemophilus influenzae.

Authors:  H Beeuwkes; V H Rutgers
Journal:  Infection       Date:  1981       Impact factor: 3.553

6.  Complementary activity of mezlocillin and the combination of amoxicillin with clavulanic acid on Enterobacteriaceae.

Authors:  C Roy; A Foz; M Tirado; C Fuster; C Segura
Journal:  Infection       Date:  1982       Impact factor: 3.553
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.